撤回：贝伐单抗联合化疗治疗卵巢癌对患者伤口愈合的影响：一项荟萃分析。
RETRACTION: Effect of Bevacizumab in Combination With Chemotherapy for Ovarian Cancer on Wound Healing in Patients: A Meta-Analysis.
出版信息
Int Wound J. 2025 Mar;22(3):e70358. doi: 10.1111/iwj.70358.
Y. Xue and F. Zhao, "Effect of Bevacizumab in Combination with Chemotherapy for Ovarian Cancer on Wound Healing in Patients: A Meta-Analysis," International Wound Journal 21, no. 4 (2024): e14531, https://doi.org/10.1111/iwj.14531. The above article, published online on 27 December 2023, in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor in Chief, Professor Keith Harding; and John Wiley & Sons Ltd. Following an investigation by the publisher, all parties have concluded that this article was accepted solely on the basis of a compromised peer review process. The editors have therefore decided to retract the article. The authors did not respond to our notice regarding the retraction.
薛阳和赵峰，“贝伐单抗联合化疗治疗卵巢癌对患者伤口愈合的影响：一项荟萃分析”，《国际伤口杂志》21卷，第4期（2024年）：e14531，https://doi.org/10.1111/iwj.14531 。上述文章于2023年12月27日在线发表于威利在线图书馆（http://onlinelibrary.wiley.com/），已根据期刊主编基思·哈丁教授与约翰·威利父子有限公司的协议撤回。经过出版商的调查，各方得出结论，这篇文章完全是基于有问题的同行评审过程而被接受的。因此，编辑们决定撤回这篇文章。作者未对我们关于撤回的通知作出回应。
Zotero 插件